• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number ECH470045A
Device Problems Occlusion Within Device (1423); Material Separation (1562)
Patient Problem Foreign Body In Patient (2687)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Review of device manufacturing record history confirmed device met pre-release specifications.Device remains implanted; therefore, direct product analysis was not possible.Ifu vascular access procedures states: the gore® acuseal vascular graft can be cannulated early (within 24 hours after implantation).Patients should be carefully monitored when using gore® acuseal vascular grafts for vascular access.Puncture sites must be adequately separated when repeated needle punctures of the graft are necessary.Multiple punctures in the same area may lead to disruption of the graft material or formation of a perigraft hematoma or pseudoaneurysm.For additional information on early cannulation and vascular access, refer to the brochure "gore-tex® vascular grafts for hemodialysis: techniques for the care and cannulation of a-v grafts", available from w.L.Gore & associates.
 
Event Description
Approximately six months to one year ago, a gore® acuseal vascular graft was implanted in a patient's arm in an arteriovenous access application.As reported, the graft had been cannulated numerous times for dialysis since implant date.Recently (date unknown), the graft thrombosed.During the intervention, it was found the graft layers had separated, possibly due to the multiple cannulations.The vascular graft remains implanted and was abandoned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® ACUSEAL VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
genevieve begay
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6440761
MDR Text Key71100837
Report Number2017233-2017-00174
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130215
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/08/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/25/2018
Device Catalogue NumberECH470045A
Device Lot Number4939752PP028
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/28/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/26/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-